Advanced search

Combine gene, variant, phenotype, region and year filters

Every result shows the extracted entities next to the sentences that support them; rows for the searched entities come first.

Transparent by designEvery result links extracted entities to its source sentence and publication identifier.
About your search

IRF3 and inflammatory bowel disease are reported together in 1 article.

Gene

IRF3

HGNC
HGNC:6118
10articles
10mentions
0variants with confirmed gene link
Most co-reported phenotypes (articles)
693articles
693mentions
12co-reported genes shown
Most co-reported genes (articles)

Counts are literature co-mentions in SaudiVarKB, not clinical or causal assertions. Gene details: HGNC; variant status: ClinVar via dbSNP.

Publications

1 records shown · first 60

Canagliflozin ameliorates ulcerative colitis via regulation of TLR4/MAPK/NF-κB and Nrf2/PPAR-γ/SIRT1 signaling pathways.

PMID 37898288 | DOI 10.1016/j.ejphar.2023.176166 · European journal of pharmacology · 2023 · 5 validated mentions
TypeEntitySource evidenceConfidenceExtractor
geneIRF3“Canagliflozin attenuates inflammation in AA-induced colitis, evidenced by significant and dose-dependently downregulation of p38 MAPK, NF-κB-p65, IKK, IRF3, and NADPH-oxidase as well as colonic levels of IL-6 and IL-1β and MPO enzymatic activity.”0.98hgnc_dict_v1
phenotypeinflammatory bowel disease“Ulcerative colitis (UC) is one of the most common subtypes of inflammatory bowel disease (IBD) that affects the colon and is characterized by severe intestinal inflammation.”0.98phenotype_alias_lexicon_v2
geneTLR4“Canagliflozin ameliorates ulcerative colitis via regulation of TLR4/MAPK/NF-κB and Nrf2/PPAR-γ/SIRT1 signaling pathways.”0.98hgnc_dict_v1
geneSIRT1“Canagliflozin ameliorates ulcerative colitis via regulation of TLR4/MAPK/NF-κB and Nrf2/PPAR-γ/SIRT1 signaling pathways.”0.98hgnc_dict_v1